These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27648776)

  • 1. Pharmacological approaches to restoring lens transparency: Real world applications.
    Skinner C; Miraldi Utz V
    Ophthalmic Genet; 2017; 38(3):201-205. PubMed ID: 27648776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanosterol reverses protein aggregation in cataracts.
    Zhao L; Chen XJ; Zhu J; Xi YB; Yang X; Hu LD; Ouyang H; Patel SH; Jin X; Lin D; Wu F; Flagg K; Cai H; Li G; Cao G; Lin Y; Chen D; Wen C; Chung C; Wang Y; Qiu A; Yeh E; Wang W; Hu X; Grob S; Abagyan R; Su Z; Tjondro HC; Zhao XJ; Luo H; Hou R; Jefferson J; Perry P; Gao W; Kozak I; Granet D; Li Y; Sun X; Wang J; Zhang L; Liu Y; Yan YB; Zhang K
    Nature; 2015 Jul; 523(7562):607-11. PubMed ID: 26200341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms.
    Chen XJ; Hu LD; Yao K; Yan YB
    Biochem Biophys Res Commun; 2018 Dec; 506(4):868-873. PubMed ID: 30392915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological chaperone for α-crystallin partially restores transparency in cataract models.
    Makley LN; McMenimen KA; DeVree BT; Goldman JW; McGlasson BN; Rajagopal P; Dunyak BM; McQuade TJ; Thompson AD; Sunahara R; Klevit RE; Andley UP; Gestwicki JE
    Science; 2015 Nov; 350(6261):674-7. PubMed ID: 26542570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts.
    Daszynski DM; Santhoshkumar P; Phadte AS; Sharma KK; Zhong HA; Lou MF; Kador PF
    Sci Rep; 2019 Jun; 9(1):8459. PubMed ID: 31186457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in pharmacotherapy of cataracts.
    Xu J; Fu Q; Chen X; Yao K
    Ann Transl Med; 2020 Nov; 8(22):1552. PubMed ID: 33313297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. βB2 W151R mutant is prone to degradation, aggregation and exposes the hydrophobic side chains in the fourth Greek Key motif.
    Xu J; Wang H; Wang A; Xu J; Fu C; Jia Z; Yao K; Chen X
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166018. PubMed ID: 33246011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of arginine mutations on the structure and functions of α-crystallin.
    Panda AK; Nandi SK; Chakraborty A; Nagaraj RH; Biswas A
    Biochim Biophys Acta; 2016 Jan; 1860(1 Pt B):199-210. PubMed ID: 26080000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives To Reverse Mutant-Crystallin-Induced Protein Aggregation.
    Yang X; Chen XJ; Yang Z; Xi YB; Wang L; Wu Y; Yan YB; Rao Y
    J Med Chem; 2018 Oct; 61(19):8693-8706. PubMed ID: 30153006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lanosterol on human cataract nucleus.
    Shanmugam PM; Barigali A; Kadaskar J; Borgohain S; Mishra DK; Ramanjulu R; Minija CK
    Indian J Ophthalmol; 2015 Dec; 63(12):888-90. PubMed ID: 26862091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein misfolding and aggregation in cataract disease and prospects for prevention.
    Moreau KL; King JA
    Trends Mol Med; 2012 May; 18(5):273-82. PubMed ID: 22520268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lens cytoplasmic phase separation.
    Clark JI; Clark JM
    Int Rev Cytol; 2000; 192():171-87. PubMed ID: 10553279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Lipoic acid alters post-translational modifications and protects the chaperone activity of lens alpha-crystallin in naphthalene-induced cataract.
    Chen Y; Yi L; Yan G; Fang Y; Jang Y; Wu X; Zhou X; Wei L
    Curr Eye Res; 2010 Jul; 35(7):620-30. PubMed ID: 20597648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha B- and βA3-crystallins containing d-aspartic acids exist in a monomeric state.
    Sakaue H; Takata T; Fujii N; Sasaki H; Fujii N
    Biochim Biophys Acta; 2015 Jan; 1854(1):1-9. PubMed ID: 25450505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isomerization of aspartyl residues in crystallins and its influence upon cataract.
    Fujii N; Takata T; Fujii N; Aki K
    Biochim Biophys Acta; 2016 Jan; 1860(1 Pt B):183-91. PubMed ID: 26275494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AlphaA-crystallin expression prevents gamma-crystallin insolubility and cataract formation in the zebrafish cloche mutant lens.
    Goishi K; Shimizu A; Najarro G; Watanabe S; Rogers R; Zon LI; Klagsbrun M
    Development; 2006 Jul; 133(13):2585-93. PubMed ID: 16728471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of alpha-crystallin chaperone activity: a target to prevent or delay cataract?
    Kumar PA; Reddy GB
    IUBMB Life; 2009 May; 61(5):485-95. PubMed ID: 19391162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sHSP in the eye lens: crystallin mutations, cataract and proteostasis.
    Clark AR; Lubsen NH; Slingsby C
    Int J Biochem Cell Biol; 2012 Oct; 44(10):1687-97. PubMed ID: 22405853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-based treatment strategies for cataract.
    Cetinel S; Unsworth L; Montemagno C
    J Glaucoma; 2014; 23(8 Suppl 1):S73-6. PubMed ID: 25275913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of α-crystallins: Traversing from in vitro to in vivo.
    Haslbeck M; Peschek J; Buchner J; Weinkauf S
    Biochim Biophys Acta; 2016 Jan; 1860(1 Pt B):149-66. PubMed ID: 26116912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.